Abound Wealth Management
RVMD icon

Abound Wealth Management’s Revolution Medicines RVMD Stock Holding History

Abound Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$411 Hold
2
– – ﹤0.01% 1068
2026
Q2 		$375 Buy
+2
New +$292 ﹤0.01% 998

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Abound Wealth Management's RVMD Position: Q3 2026 in Review

Abound Wealth Management held its Revolution Medicines (RVMD) position steady in Q3 2026 at 2 shares worth $411. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Abound Wealth Management first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Abound Wealth Management held 2 shares of Revolution Medicines worth $411 as of Q3 2026.
  • Abound Wealth Management left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1068 holding.
  • Abound Wealth Management first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.